Top Story

Top HCV studies presented at ICAAC

September 26, 2014

Healio.com/Hepatology has compiled a list of the latest, most relevant research on hepatitis C virus infection presented recently at ICAAC 2014 in Washington, D.C.

EMA committee recommends Harvoni to treat HCV

September 26, 2014
The European Medicines Agency’s Committee for Medicinal Products for Human Use recommends a marketing authorization application for ledipasvir/sofosbuvir as…
figure

St. Louis University to test sofosbuvir/ribavirin in pediatric HCV cases

September 23, 2014
Researchers at Saint Louis University will begin study enrollment to test the safety and efficacy of sofosbuvir with ribavirin to treat hepatitis C virus infection in…
In the Journals

Acute HIV infection may help control chronic HBV

September 22, 2014
According to researchers from Beijing You’an Hospital, Capital Medical University in China, the effects of acute HIV infection improve the immune response to…
CME
figure

HCV Consults: Volume 1, Number 3

This activity is supported by educational grants from AbbVie and Genentech, Inc.

Chronic HCV infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular carcinoma, and death…
More »
Meeting News Coverage Video
figure

Tenofovir/entecavir recommended for HBV patients with malignancy

May 16, 2014
CHICAGO — Spilios Manolakopoulos, MD, of the internal medicine and hepatology departments at…
More »
CME
figure

CRITICAL ISSUES IN HBV: Considerations in Optimizing HBV Treatment

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

Hepatitis B virus (HBV) infection is a global epidemic with a worldwide burden. Physicians must address the importance…
More »

Filter By:

figure

Top HCV studies presented at ICAAC

September 26, 2014
Healio.com/Hepatology has compiled a list of the latest, most relevant research on hepatitis C virus infection presented recently at ICAAC 2014 in…

EMA committee recommends Harvoni to treat HCV

September 26, 2014
The European Medicines Agency’s Committee for Medicinal Products for Human Use recommends a marketing authorization application for…
figure

St. Louis University to test sofosbuvir/ribavirin in pediatric HCV cases

September 23, 2014
Researchers at Saint Louis University will begin study enrollment to test the safety and efficacy of sofosbuvir with ribavirin to treat hepatitis C…
In the Journals

Acute HIV infection may help control chronic HBV

September 22, 2014
According to researchers from Beijing You’an Hospital, Capital Medical University in China, the effects of acute HIV infection improve the…

Patent filed for injectable HBV, liver cancer drug in China

September 18, 2014
Biostar Pharmaceuticals has filed an invention and creation patent application in China for oleanolic acid injection for the treatment of hepatitis B…
In the Journals

Half of patients with HIV not screened regularly for HCV

September 17, 2014
Researchers from Boston Medical Center have found that although most patients with HIV were screened for hepatitis C virus infection when enrolling…

Sovaldi use decreased; analysts anticipate rise with release of newer therapies for HCV

September 17, 2014
The rate at which patients have used sofosbuvir to treat hepatitis C virus infection has declined in recent months, according to an analysis…
figure In the Journals

HAV in the Middle East and North Africa region declined in younger populations

September 17, 2014
Seroprevalence trends in hepatitis A virus infection indicated a decline among younger populations in the Middle East and North Africa region, while…

Gilead OKs generic licensing deals in India for Sovaldi

September 15, 2014
Gilead Sciences has signed licensing agreements that will allow seven Indian pharmaceutical manufacturers to produce generic versions of sofosbuvir…
Meeting News Coverage

HBV, HIV seroprevalence high among pregnant women at Cameroon clinic

September 9, 2014
WASHINGTON, D.C. — Pregnant women in Cameroon had a high seroprevalence for hepatitis B virus infection and HIV, but not hepatitis C virus…
More Headlines »